According to a new report published by Allied Market Research, titled, โ€œProteomics Market by Component and Application: Opportunity Analysis and Industry Forecast, 2019-2027,โ€ the global proteomics market was valued at $21.12 billion in 2019, and is projected to reach $49.97 billion by 2027 at a CAGR of 12.2% from 2020 to 2027. Proteomics has the capacity to explain questions that were unsolved by genomics, as proteins are the functional unit of cells. Advancements in technologies such as mass spectrometry and chromatography and development of computer algorithms for database searching facilitate proteomics research. The analysis of target proteins for disease diagnosis is the largest application of proteomics.

๐‹๐ข๐ฌ๐ญ ๐จ๐Ÿ ๐Š๐ž๐ฒ ๐๐ฅ๐š๐ฒ๐ž๐ซ๐ฌ :

The key companies profiled in the proteomics market report include Agilent Technologies Inc., Danaher Corporation, LI-COR, Inc., PerkinElmer, Inc., Thermo Fisher Scientific, Inc., HORIBA, Ltd., Bio-Rad Laboratories, Inc., Bruker Corporation, General Electric (GE), and Waters Corporation. The other players included in the value chain analysis (but not included in the report) are Becton, Dickinson and Company, Caprion Biosciences, and others.

๐ƒ๐จ๐ฐ๐ง๐ฅ๐จ๐š๐ ๐’๐š๐ฆ๐ฉ๐ฅ๐ž ๐‘๐ž๐ฉ๐จ๐ซ๐ญ

๐Š๐„๐˜ ๐…๐ˆ๐๐ƒ๐ˆ๐๐†๐’ ๐Ž๐… ๐“๐‡๐„ ๐’๐“๐”๐ƒ๐˜

  • The reagents segment generated the highest revenue in 2019, and is projected to grow at a CAGR of 11.7% during the forecast period.
  • The instruments segment is anticipated to grow at the highest CAGR throughout the forecast period.
  • Drug discovery dominated the global proteomics applications market in 2019, accounting for nearly 60.0% of the share of the proteomics market size in 2019.
  • In 2019, the U.S. was the leading country, occupying the largest proteomics market share in North America.

๐—–๐—ผ๐˜ƒ๐—ถ๐—ฑ-๐Ÿญ๐Ÿต ๐—ฆ๐—ฐ๐—ฒ๐—ป๐—ฎ๐—ฟ๐—ถ๐—ผ:

Most markets are dropping down as COVID-19 outbreak has negatively affected various healthcare related markets. The development of therapeutic and preventive strategies requires an accurate understanding of the role that proteins play in the SARS-CoV-2 infection process and progression of COVID-19. A wide array of identification and separation techniques can isolate proteins from complex mixtures, facilitating the analysis of protein-protein interactions, temporal expression patterns and cellular or subcellular distribution. For instance, most common separation methods are one- and two-dimensional gel electrophoresis and high-performance liquid chromatography, whereas mass spectrometry (MS) forms the backbone of protein detection and identification. MS-based detection can provide simple and rapid detection of SARS-CoV-2, even among recovered patients. Hence, in the perspective of COVID-19, proteomics can help to reveal novel biomarkers and define point-of-care procedures that could mean cost-effective healthcare can be delivered closer to the patient.

๐…๐จ๐ซ ๐๐ฎ๐ซ๐œ๐ก๐š๐ฌ๐ž ๐ˆ๐ง๐ช๐ฎ๐ข๐ซ๐ฒ

The protein microarray segment generated the highest revenue in 2019 in the proteomics instruments market, owing to high usage of this technology to track protein interactions in lesser time as compared to other technologies. Moreover, this method is labor-intensive and cost-effective. With the help of protein array, the comprehensive information about the DNA/RNA binding proteins can be made available.
By reagents segment, immunoassays held the highest proteomics market share in the total market, as they are extensively utilized in primary screening in drug discovery and microarray technologies. On the basis of application, the drug discovery segment accounted for the majority market share in 2019, owing to increase in awareness of personalized medicines in both emerging and developed markets, thereby boosting the proteomics market growth in coming years. 

North America held the largest proteomics market share of nearly 39.0% of the total market in 2019, due to increase in popularity and adoption of personalized medicines and favorable government funding & initiatives to develop novel therapeutics. However, Asia-Pacific is expected to grow at a CAGR of 15.6% from 2019 to 2027, owing to rise in prevalence of chronic diseases and increase in interest of researchers to utilize proteomics in disease diagnosis & treatment.

๐—š๐—ฒ๐˜ ๐——๐—ฒ๐˜๐—ฎ๐—ถ๐—น๐—ฒ๐—ฑ ๐‘๐ž๐ฉ๐จ๐ซ๐ญ

๐Ž๐ญ๐ก๐ž๐ซ ๐“๐ซ๐ž๐ง๐๐ข๐ง๐  ๐‘๐ž๐ฉ๐จ๐ซ๐ญ๐ฌ:

Soft Tissue Repair Market

Insulin Syringes Market

About Us

Allied Market Research (AMR) is a full-service market research and business-consulting wing of Allied Analytics LLP based in Portland, Oregon. Allied Market Research provides global enterprises as well as medium and small businesses with unmatched quality of โ€œMarket Research Reportsโ€ and โ€œBusiness Intelligence Solutions.โ€ AMR has a targeted view to provide business insights and consulting to assist its clients to make strategic business decisions and achieve sustainable growth in their respective market domain.

Pawan Kumar, the CEO of Allied Market Research, is leading the organization toward providing high-quality data and insights. We are in professional corporate relations with various companies and this helps us in digging out market data that helps us generate accurate research data tables and confirms utmost accuracy in our market forecasting. Each and every data presented in the reports published by us is extracted through primary interviews with top officials from leading companies of domain concerned. Our secondary data procurement methodology includes deep online and offline research and discussion with knowledgeable professionals and analysts in the industry.


David Correa
5933 NE Win Sivers Drive
205, Portland, OR 97220
United States
USA/Canada (Toll Free): +1-800-792-5285, +1-503-894-6022
UK: +44-845-528-1300
Hong Kong: +852-301-84916
India (Pune): +91-20-66346060
Fax: +1(855)550-5975

Leave a comment

Your email address will not be published. Required fields are marked *